Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 17, 2023

Primary Completion Date

September 16, 2026

Study Completion Date

September 16, 2027

Conditions
Ovarian CancerQuality of Life
Interventions
OTHER

Patients that are HRP are given a decision aid for PARPi use

Study created patient decision aid if the first for HRD tested Ovarian Cancer patients

Trial Locations (1)

S7V4H4

RECRUITING

Saskatchewan Cancer Center, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER